Lv1
10 积分 2025-01-04 加入
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
15天前
已完结
Characterization of heavy-chain antibody gene repertoires in Bactrian camels
1个月前
已完结
Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
Nasal delivery of secretory IgA confers enhanced neutralizing activity against Omicron variants compared to its IgG counterpart
1个月前
已完结
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial
2个月前
已完结
Optimized Workflow from Gene to Product
2个月前
已关闭
Applications of Nanobodies
2个月前
已完结
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218
2个月前
已关闭
Chikungunya vaccine development, challenges, and pathway toward public health impact
2个月前
已完结
皖公网安备34019202002308
